Microalgae-Derived Nanoparticles Shield Skin From Radiation Damage
Scientists engineer Spirulina-based extracellular vesicles loaded with astaxanthin to protect skin cells from radiation injury by restoring mitochondrial health.
Summary
Researchers at Zhejiang University engineered extracellular vesicles (EVs) from the microalgae Spirulina platensis, loading them with the potent antioxidant astaxanthin to create SP-EVs@AST. This system combats radiodermatitis — painful radiation-induced skin damage affecting most cancer patients undergoing radiotherapy — by reducing oxidative stress, restoring mitochondrial function, and dampening inflammation. To enable practical skin application, the engineered vesicles were embedded in a self-assembling hydrogel dressing made from hyaluronic acid and carboxymethyl chitosan, enabling sustained drug release. The resulting dressing showed strong protective effects against progressive radiation injury with a favorable safety profile, positioning engineered microalgal EVs as a versatile, biocompatible drug delivery platform for poorly soluble therapeutic compounds.
Detailed Summary
Radiodermatitis affects the majority of cancer patients receiving radiotherapy and can range from mild redness to severe, debilitating skin breakdown. Despite its prevalence, effective preventive strategies remain limited, largely because radiation-induced damage involves complex, interconnected pathways including oxidative stress, mitochondrial dysfunction, and chronic inflammation. A new study published in ACS Nano proposes an elegant biological engineering solution to this clinical gap.
The research team isolated natural extracellular vesicles from Spirulina platensis, a well-studied edible microalgae known for its antioxidant and anti-inflammatory properties. These vesicles were then loaded with astaxanthin (AST), a powerful carotenoid antioxidant notorious for its poor water solubility and bioavailability. Encapsulation within SP-EVs significantly improved AST's stability and solubility while preserving the vesicles' own biological activity, creating a synergistic therapeutic system.
In cellular experiments, SP-EVs@AST protected against radiation-induced damage by scavenging reactive oxygen species, restoring mitochondrial membrane potential and function, and reducing inflammatory signaling. Mitochondrial homeostasis is increasingly recognized as a central node in aging and tissue resilience, making its restoration particularly relevant to longevity science.
To translate the formulation into a practical skin treatment, the team incorporated SP-EVs@AST into a dynamic hydrogel formed from aldehyde-functionalized hyaluronic acid and carboxymethyl chitosan. This dressing enabled sustained, controlled release of the therapeutic cargo and demonstrated protection against progressive radiation skin injury in preclinical models, with strong long-term biocompatibility.
While findings are promising, this study is preclinical, relying on cell-based and likely animal models. Clinical translation will require rigorous human trials. Nevertheless, the platform demonstrates broad potential as a natural, biocompatible delivery system for poorly soluble drugs across multiple biomedical applications.
Key Findings
- Spirulina-derived EVs loaded with astaxanthin synergistically reduced radiation-induced oxidative stress and inflammation in skin cells.
- SP-EVs@AST restored mitochondrial membrane function and homeostasis following radiation exposure.
- Encapsulation in SP-EVs significantly improved astaxanthin's solubility, stability, and biological activity.
- A hyaluronic acid–chitosan hydrogel dressing enabled sustained release of SP-EVs@AST with long-term safety.
- The engineered platform offers a generalizable microalgal EV delivery system for poorly soluble therapeutic drugs.
Methodology
The study isolated EVs from Spirulina platensis microalgae and loaded them with astaxanthin to create SP-EVs@AST. Protective effects were assessed in radiation-exposed cellular models measuring oxidative stress, mitochondrial function, and inflammation. A topical hydrogel dressing was formulated from aldehyde-hyaluronic acid and carboxymethyl chitosan for sustained delivery and evaluated for skin protection and biosafety.
Study Limitations
This is a preclinical study; human clinical trial data are absent, limiting direct translation of findings. The abstract does not specify which animal models were used or the extent of in vivo validation. Long-term stability and shelf-life of the hydrogel dressing under real-world storage conditions are not addressed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.